Abcam (ABC)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

1,145.00p
   
  • Change Today:
      23.00p
  • 52 Week High: 1,750.00
  • 52 Week Low: 1,049.00
  • Currency: UK Pounds
  • Shares Issued: 228.94m
  • Volume: 117,147
  • Market Cap: 2,621.37m
  • RiskGrade: 134

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-18 233.20 69.10 32.70p 40.8 1.5 +27% 12.00p 0.9%
30-Jun-19 259.90 56.40 32.90p 44.8 44.8 +1% 12.13p 0.8%
30-Jun-20 260.00 8.40 16.70p 79.8 n/a -49% 3.55p 0.3%
30-Jun-21 297.70 25.40 13.70p 100.8 n/a -18% n/a 0.0%
31-Dec-21 462.90 20.30 65.86p 26.3 0.1 +381% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 383.12 82.38 29.07p 39.4 n/a -56% 1.05p 0.1%
31-Dec-23 428.77 106.80 36.41p 31.4 1.2 +25% 1.31p 0.1%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 40.80 26.31 58.51 0.30

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Abcam Market Data

Currency UK Pounds
Share Price 1,145.00p
Change Today 23.00p
% Change 2.05 %
52 Week High 1,750.00
52 Week Low 1,049.00
Volume 117,147
Shares Issued 228.94m
Market Cap 2,621.37m
RiskGrade 134

Abcam Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.66% below the market average92.66% below the market average92.66% below the market average92.66% below the market average92.66% below the market average
89.29% below the sector average89.29% below the sector average89.29% below the sector average89.29% below the sector average89.29% below the sector average
Price Trend
63.71% below the market average63.71% below the market average63.71% below the market average63.71% below the market average63.71% below the market average
7.94% above the sector average7.94% above the sector average7.94% above the sector average7.94% above the sector average7.94% above the sector average
Income
97.19% below the market average97.19% below the market average97.19% below the market average97.19% below the market average97.19% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
96.50% above the market average96.50% above the market average96.50% above the market average96.50% above the market average96.50% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 4
Buy 1
Neutral 8
Sell 0
Strong Sell 0
Total 13
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Abcam Dividends

  Latest Previous
  Interim Final
Ex-Div 19-Mar-20 07-Nov-19
Paid 17-Apr-20 29-Nov-19
Amount 3.55p 8.58p

Trades for 26-May-2022

Time Volume / Share Price
16:35 24,562 @ 1,145.00p
16:29 2 @ 1,144.00p
16:29 23 @ 1,145.00p
16:29 2 @ 1,145.00p
16:29 2 @ 1,145.00p

Abcam Key Personnel

CEO Alan Thomas Hirzel
CFO Michael Baldock

Top of Page